ironwood pharmaceuticals appoints lawrence olanoff md phd to board of directors nasdaqirwd             share this on delicious digg facebook linkedin twitter what is this « previous release  next release » april   ironwood pharmaceuticals appoints lawrence olanoff md phd to board of directors cambridge massbusiness wire ironwood pharmaceuticals inc nasdaq irwd announced today the appointment of lawrence olanoff md phd to its board of directors as well as to its pharmaceutical advisory committee dr olanoff has more than  years of pharmaceutical industry experience and has been a leader in clinical development discovery research strategy and operations for several companies ranging from small biotechnology firms to large pharmaceutical corporations most recently he served as a director and as chief operating officer of forest laboratories inc ironwood also announced that current board members joseph cook jr and david ebersman have decided to transition off of ironwoods board of directors at the end of their current terms in office at ironwoods  annual meeting of stockholders ironwood is committed to attracting board members who have business savvy a strong interest in our company absolute integrity great strategic judgment and an owneroriented mindset we believe larry has each of these qualities as well as tremendous breadth of experience guiding the development of more than  fdaapproved drugs utilized across a broad range of therapeutic needs he is a great clinical pharmacologist with extensive knowledge of pharmaceutical development and regulatory history and he is also a masterful business strategist and leader this rare combination of skills makes larry a valuable representative of our shareholders and advisor to our scientists said peter hecht chief executive officer of ironwood hecht continued as i welcome larry to the board i would also like to recognize joe and david for their years of service to our shareholders joe has been an ironwood director since cofounding the company in  and has impacted virtually every significant decision we have made shaping our strategy development and culture while helping us to remain focused on the needs of patients similarly davids strategic wisdom has guided ironwood through many opportunities as we have grown as an organization i have had the opportunity to work collaboratively with the ironwood team over the years and i have developed great respect for their ingenuity and ability to innovate they brought the first in a new class of gastrointestinal products to the market developed an innovative commercialization strategy to deliver that product to patients and physicians and built a pipeline of gastrointestinal programs targeting diseases that impact millions of patients said dr olanoff i look forward to joining ironwoods esteemed board and in my role with the pharmaceutical advisory committee collaborating closely with their impressive rd team dr olanoff most recently served as a director and as chief operating officer and previously as executive vice president and chief scientific officer of forest laboratories inc acquired by actavis plc he also previously served as president and chief executive officer of celsion corporation senior vice president of clinical research and development at sandoz pharmaceutical corporation now a division of the novartis group and in a number of positions at the upjohn company dr olanoff is currently an adjunct assistant professor and special advisor to the president for corporate relations at the medical university of south carolina musc a member of the musc foundation for research development board and chairman of the board of the clinical biotechnology research institute at roper st francis hospital he received his doctorate in biomedical engineering and medical doctor degree from case western reserve university about ironwood pharmaceuticals ironwood pharmaceuticals nasdaq irwd is focused on creating medicines that make a difference for patients building value to earn the continued support of our fellow shareholders and empowering our team to passionately pursue excellence we discovered developed and are commercializing linaclotide which is approved in the united states and a number of other countries our pipeline priorities include exploring further opportunities for linaclotide as well as leveraging our therapeutic expertise in gastrointestinal disorders and our pharmacologic expertise in guanylate cyclases to address patient needs across the upper and lower gastrointestinal tract ironwood was founded in  and is headquartered in cambridge mass connect with us at wwwironwoodpharmacom or on twitter at wwwtwittercomironwoodpharma information that may be important to investors will be routinely posted in both these locations any trademarks referred to in this press release are the property of their respective owners all rights reserved ironwood pharmaceuticals incmedia relationstrista morrison director corporate communicationstmorrisonironwoodpharmacomorinvestor relationsmeredith kaya director investor relationsmkayaironwoodpharmacom source ironwood pharmaceuticals inc news provided by acquire media close window  back to top delicious digg facebook linkedin twitter copyright  ironwood pharmaceuticals inc dr lawrence s olanoff md phd skip navigation  about frdcontact us home staffboard of directorscontact  directions lawrence s olanoff md phd special advisor to the president for corporate relations muscdr olanoff is special advisor to the president for corporate relations at musc after a long career in the pharmaceutical industry he retired from his last position as president and chief operating officer  at forest laboratories inc and currently serves as a director of forest laboratories inc  dr olanoff was president and chief executive officer of celsion corporation from  to   from  until  dr olanoff was responsible for the leadership of research and development activities for forest laboratories inc ultimately as its executive vice presidentscientific affairs from  to  dr olanoff was senior vice presidentclinical research and development at sandoz pharmaceutical corporation from  to  dr olanoff was employed by the upjohn company where his last position was corporate vice presidentclinical development and medical affairsdr olanoff holds md and phd biomedical engineering degrees from case western reserve university and was a medical resident and clinical pharmacology fellow at musc he is the author or coauthor of numerous scientific publications in the fields of clinical pharmacology drug delivery and pharmacokineticsmusc foundation for research development harborview office tower  hagood avenue suite  charleston sc     ph   fx    musc foundation for research development    dr lawrence s olanoff md phd skip navigation  about frdcontact us home staffboard of directorscontact  directions lawrence s olanoff md phd special advisor to the president for corporate relations muscdr olanoff is special advisor to the president for corporate relations at musc after a long career in the pharmaceutical industry he retired from his last position as president and chief operating officer  at forest laboratories inc and currently serves as a director of forest laboratories inc  dr olanoff was president and chief executive officer of celsion corporation from  to   from  until  dr olanoff was responsible for the leadership of research and development activities for forest laboratories inc ultimately as its executive vice presidentscientific affairs from  to  dr olanoff was senior vice presidentclinical research and development at sandoz pharmaceutical corporation from  to  dr olanoff was employed by the upjohn company where his last position was corporate vice presidentclinical development and medical affairsdr olanoff holds md and phd biomedical engineering degrees from case western reserve university and was a medical resident and clinical pharmacology fellow at musc he is the author or coauthor of numerous scientific publications in the fields of clinical pharmacology drug delivery and pharmacokineticsmusc foundation for research development harborview office tower  hagood avenue suite  charleston sc     ph   fx    musc foundation for research development    lawrence s olanoff  dollars for docs  propublica propublica see more atvital signs dollars for docs how industry dollars reach your doctors has your doctor received drug or device company money all statesalabama alaska american samoa arizona arkansas armed forces americas armed forces europe armed forces pacific california colorado connecticut delaware district of columbia florida georgia guam hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota northern mariana islands ohio oklahoma oregon pennsylvania puerto rico rhode island south carolina south dakota tennessee texas utah vermont virginia virgin islands washington west virginia wisconsin wyoming for example andrew jones boston  dollars for docs » south carolina » lawrence s olanoff is this your doctor print out this record along with questions and tips for talking with your physician about payments have you used or plan to use this information tell us about it lawrence s olanoff listed specialty  greensward rd kiawah island sc  search this name in dollars for docs archive » is this you do you believe the data contains errors click here for information » is this your doctor print out this record along with questions and tips for talking with your physician about payments have you used or plan to use this information tell us about it lawrence olanoff yearly payment breakdown    all payments at a glance   payments  payment total  companies paid this doctor   payments  payment total  companies paid this doctor   payments  payment total  company paid this doctor payment calendar in this doctor received a payment on days in  each box below represents a single day during the disclosure period a gray box indicates no payments the darker the color the more payments a doctor received that day types of payments in category payments payment value promotional speakingother  k promotional speakingother  k consulting  k consulting   consulting   travel and lodging   travel and lodging   food and beverage   food and beverage   food and beverage   drugs  devices in totals listed below account for all payments from august  to december  that mention this product if a payment record mentions more than one product the entire value will be included in each of those products this physician does not have any payments relating to a specific drug or device for this year product name product type payments† linzess drug  † may not add up to dollar total at top of page since a payment record may not be associated with any product or can be associated with several products product name product type payments† linzess drug  † may not add up to dollar total at top of page since a payment record may not be associated with any product or can be associated with several products payment details in when how much related to what for from third party payee jul    no listed product promotional speakingother forest laboratories inc aug    no listed product promotional speakingother forest laboratories inc aug    no listed product consulting forest laboratories inc oct    no listed product consulting forest laboratories inc nov    no listed product consulting forest laboratories inc may    no listed product promotional speakingother forest laboratories inc dec    no listed product consulting forest laboratories inc oct    no listed product consulting forest laboratories inc sep    no listed product consulting forest laboratories inc aug    no listed product consulting forest laboratories inc jan    no listed product promotional speakingother forest laboratories inc feb    no listed product promotional speakingother forest laboratories inc nov    no listed product consulting forest laboratories inc mar    no listed product promotional speakingother forest laboratories inc apr    no listed product promotional speakingother forest laboratories inc jun    no listed product promotional speakingother forest laboratories inc mar    no listed product promotional speakingother forest laboratories inc dec    no listed product consulting forest laboratories inc aug    no listed product consulting ironwood pharmaceuticals inc mar    no listed product consulting ironwood pharmaceuticals inc dec    no listed product consulting forest laboratories inc aug    no listed product consulting forest laboratories inc mar    no listed product promotional speakingother forest laboratories inc mar    no listed product consulting forest laboratories inc jan    no listed product promotional speakingother forest laboratories inc dec    no listed product consulting forest laboratories inc apr    no listed product consulting forest laboratories inc oct    no listed product consulting forest laboratories inc may    no listed product consulting forest laboratories inc mar    no listed product consulting forest laboratories inc dec    no listed product consulting forest laboratories inc may    no listed product consulting forest laboratories inc aug    no listed product travel and lodging forest laboratories inc mar    no listed product travel and lodging forest laboratories inc dec    no listed product travel and lodging forest laboratories inc sep    no listed product consulting forest laboratories inc jan    no listed product promotional speakingother forest laboratories inc jan    no listed product promotional speakingother forest laboratories inc may    no listed product promotional speakingother forest laboratories inc apr    no listed product promotional speakingother forest laboratories inc feb    no listed product promotional speakingother forest laboratories inc may    no listed product travel and lodging forest laboratories inc feb    no listed product travel and lodging forest laboratories inc jan    no listed product travel and lodging forest laboratories inc may    no listed product promotional speakingother forest laboratories inc sep    no listed product consulting forest laboratories inc oct    no listed product travel and lodging forest laboratories inc may    no listed product travel and lodging forest laboratories inc aug    no listed product travel and lodging forest research institute inc oct    no listed product consulting ironwood pharmaceuticals inc nov    no listed product travel and lodging forest laboratories inc oct    no listed product travel and lodging forest laboratories inc jun    no listed product consulting ironwood pharmaceuticals inc aug    no listed product consulting forest laboratories inc oct    no listed product consulting ironwood pharmaceuticals inc aug    no listed product travel and lodging forest laboratories inc feb    no listed product travel and lodging forest laboratories inc aug    no listed product food and beverage forest research institute inc sep    linzess food and beverage ironwood pharmaceuticals inc jan    no listed product travel and lodging forest laboratories inc jan    no listed product food and beverage forest laboratories inc aug    no listed product travel and lodging forest laboratories inc feb    no listed product food and beverage forest laboratories inc mar    no listed product food and beverage forest laboratories inc oct    no listed product food and beverage forest laboratories inc feb    no listed product food and beverage ironwood pharmaceuticals inc nov    no listed product food and beverage allergan inc may    no listed product food and beverage forest laboratories inc jul    no listed product food and beverage forest laboratories inc aug    no listed product travel and lodging forest laboratories inc dec    no listed product travel and lodging forest laboratories inc nov    no listed product food and beverage allergan inc jan    no listed product food and beverage forest laboratories inc aug    no listed product food and beverage forest laboratories inc nov    linzess food and beverage ironwood pharmaceuticals inc mar    no listed product food and beverage forest laboratories inc jul    linzess food and beverage ironwood pharmaceuticals inc mar    no listed product food and beverage forest laboratories inc oct    no listed product food and beverage forest laboratories inc dec    no listed product food and beverage forest laboratories inc dec    no listed product food and beverage forest laboratories inc aug    no listed product food and beverage forest laboratories inc mar    no listed product travel and lodging forest laboratories inc nov    no listed product travel and lodging forest laboratories inc dec    no listed product travel and lodging forest laboratories inc feb    no listed product travel and lodging forest laboratories inc mar    no listed product food and beverage forest research institute inc oct    no listed product food and beverage forest laboratories inc may    no listed product food and beverage forest laboratories inc mar    no listed product food and beverage forest research institute inc aug    no listed product food and beverage forest laboratories inc aug    no listed product food and beverage forest laboratories inc dec    no listed product food and beverage forest laboratories inc aug    no listed product food and beverage forest laboratories inc oct    no listed product food and beverage forest laboratories inc jan    no listed product food and beverage forest laboratories inc sep    no listed product travel and lodging forest laboratories inc may    no listed product travel and lodging forest laboratories inc may    no listed product travel and lodging forest laboratories inc dec    no listed product travel and lodging forest laboratories inc oct    no listed product food and beverage forest laboratories inc may    no listed product food and beverage forest laboratories inc dec    no listed product food and beverage forest laboratories inc aug    no listed product food and beverage forest laboratories inc nov    no listed product food and beverage forest laboratories inc may    no listed product travel and lodging forest laboratories inc see this doctor’s open payments page » note we have made some effort to normalize the data and eliminate duplicates but data is primarily as it has been reported by the companies to the centers for medicare and medicaid services to purchase the normalized data please visit the propublica data store if you spot an error please let us know at drugspropublicaorg propublica  copyright pro publica inc   lawrence olanoff  medical university of south carolina  zoominfocom irwd lawrence s olanoff insider trades for ironwood pharmaceuticals inc cl a bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close ironwood pharmaceuticals inc cl a nasdaq irwd go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus ironwood pharmaceuticals inc cl a after hours  quotes are delayed by  min jul    pm irwd quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual lawrence s olanoff dr lawrence s olanoff md phd is independent nonemployee director at axovant sciences ltd independent director at ironwood pharmaceuticals inc chief operating officer at almirall ltd chairman at ariel pharmaceuticals inc and chairman at clinical biotechnology research institute he is on the board of directors at axovant sciences ltd ironwood pharmaceuticals inc and musc foundation for research development dr olanoff was previously employed as president chief executive officer  director by celsion corp senior vpclinical research  development by sandoz pharmaceuticals corp and vpclinical development  medical affairs by the upjohn co he also served on the board at forest laboratories inc he received his undergraduate degree from tufts university a graduate degree from rutgers university new jersey and a doctorate degree from case western reserve university transactions date shares transaction value     disposition at  per share      award at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      award at  per share      disposition at  per share      disposition at  per share      disposition at  per share      award at  per share      award at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives dr peter m hecht chief executive officer  director mr thomas graney chief financial officer  svpcorporate strategy dr brian m cali senior vppreclinical research  development dr mark g currie chief scientific officer  senior vice president dr michael l hall senior vice presidentclinical development dr christopher i wright chief development officer dr g todd milne vice presidentbiology mr james j omara vice presidentcorporate development ms amy w schulman director mr andrew dreyfus director mr thomas a mccourt chief commercial officer svpsales  marketing ms gina r consylman chief accounting officer vp  controller ms meredith kaya directorinvestor relations ms mary t conway headinvestor relations ms sharon debacco senior directorcustomer communications ms lisa adler senior vice presidentcorporate communications ms trista morrison directorcorporate communications mr jonathan rosin vice presidenthuman resources ms halley e gilbert secretary chief legal officer  senior vp mr terrance g mcguire chairman dr douglas e williams independent director mr edward p owens independent director ms marsha h fanucci independent director ms julie harris mchugh independent director dr lawrence s olanoff independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pjared kushner discloses dozens of additional assets in revised filing pbitcoin surges as miners avert split for now palphabet earnings a  billion hit for google potential youtube results for investors ahow opec committee’s coming meeting could make or break oil prices aa grandfather’s financial advice to his grandchildren awhy one analyst calls this the ‘chart of the week month and potentially year’ athe cracked benchmark why some investors want a new standard for bonds a moneymaking lessons from the richest man who ever lived age’s stock falls as jeff immelt’s th and last quarter is another disappointment anolan’s cinematic vision in ‘dunkirk’ is hollywood’s best defense against netflix aalphabet earnings a  billion hit for google potential youtube results for investors amicrosoft rides huge tax benefit from failing at smartphones to big earnings beat atrump says he has ‘complete power to pardon’ achipotle earnings media coverage of the latest illness scare will put earnings targets at risk aexxon earnings will stock trade higher on expected secondquarter beat apay tv expected to lose more than a million subscribers in latest quarter aqualcomm’s issues go beyond apple fight ayogaworks ipo pulled on valuation concerns not market conditions aamazon’s foray into groceries means more mergers of food companies experts say athis is what should really worry you about stocks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice    forbidden access is denied server error   forbidden access is denied you do not have permission to view this directory or page using the credentials that you supplied lawrence s olanoff md phd  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in lawrence s olanoff md phd board member at ironwood pharmaceuticals inc view full profile are you lawrence s olanoff md phd claim your profile   sign up for equilar atlas and view lawrence s olanoff md phds full profile with equilar atlas you can identify corporate executives in lawrence s olanoff md phds network and community follow changes in lawrence s olanoff md phds employment and moneyinmotion connect with lawrence s olanoff md phd through your network of contacts lawrence s olanoff md phds executive work history current board member ironwood pharmaceuticals inc board member axovant sciences ltd past to view lawrence s olanoff md phds complete executive work history sign up now education phd case western reserve university age      lawrence s olanoff md phds biography lawrence s olanoff md phd joined our board of directors in april  dr olanoff most recently served as chief operating officer for forest laboratories inc acquired by allergan plc from october  to december  dr olanoff also served as a director of forest from october  to july  from july  to october  dr olanoff was president and chief executive officer at celsion corporation he also served as executive vice president and chief scientific officer of forest from  to  prior to joining forest in  dr olanoff served as senior vice president of clinical research and development at sandoz phar  read more lawrence s olanoff md phd joined our board of directors in april  dr olanoff most recently served as chief operating officer for forest laboratories inc acquired by allergan plc from october  to december  dr olanoff also served as a director of forest from october  to july  from july  to october  dr olanoff was president and chief executive officer at celsion corporation he also served as executive vice president and chief scientific officer of forest from  to  prior to joining forest in  dr olanoff served as senior vice president of clinical research and development at sandoz pharmaceutical corporation now a division of the novartis group and at the upjohn company in a number of positions including corporate vice president of clinical development and medical affairs in addition he is currently an adjunct assistant professor and special advisor to the president for corporate relations at the medical university of south carolina musc an exofficio director of the musc foundation for research development chairman of the board of the clinical biotechnology research institute at roper st francis hospital and a board member of axovant sciences ltd the horizon project and the zucker institute for applied neurosciences dr olanoff received his phd in biomedical engineering and md degree from case western reserve university dr olanoffs detailed knowledge of the pharmaceutical industry his broad operational experience and his research and development leadership over the course of his career make him an important asset to our board of directors source ironwood pharmaceuticals inc on    sign up for equilar atlas and view lawrence s olanoff md phds full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like lawrence s olanoff md phd more specifically youll be able to identify corporate executives in lawrence s olanoff md phds network and community follow changes in lawrence s olanoff md phds employment and moneyinmotion connect with lawrence s olanoff md phd through your network of conections view full profile   search for over  executive profiles bio example lawrence s olanoff md phd lawrence s olanoff md phds connections  sign up now to view lawrence s olanoff md phds  connections » nicholas borys senior vice president and chief medical officer celsion corporation terrance g mcguire board member ironwood pharmaceuticals inc vincent j intrieri board member navistar international corporation michael h tardugno chairman of the board president and chief executive officer celsion corporation augustine chow pok yu board member celsion corporation christopher j coughlin lead independent director allergan plc gary w pace board member resmed inc william a vernon board member intersect ent inc ivan p gergel senior vice president drug development and chief medical officer nektar therapeutics anthony p deasey former executive vice president chief operating officer and chief financial officer celsion corporation popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith elon r musk ceo and chairman tesla jan koum board member facebook inc philip l milstein board member the marcus corporation × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login �  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   lawrence s olanoff board dir celsion corp a publisher of business information since         search business search executive   advanced search   sign in    hints profile of lawrence olanoff   lawrence olanoff   board dir  celsion corp   lawrence olanoff email  please login   company name  celsion corp   company website  wwwcelsioncom   company address   old columbia rd columbia mdunited states   lawrence olanoff profile  board dir  celsion corp   lawrence olanoff biography  dr lawrence s olanoff dr olanoff was elected to the board of directors in august  dr olanoff was appointed president and chief operating officer and a member of the board of directors of forest laboratories incorporated in october  dr olanoff served as president and chief executive officer of the company from july  until october  from  to july  dr olanoff was the senior research and development executive for forest laboratories incorporated and was appointed executive vice president scientific affairs on november   from  to  dr olanoff was senior vice presidentclinical research and development at sandoz pharmaceutical corporation for nine years prior thereto dr olanoff was employed by the upjohn company where his last position was corporate vice president clinical development and medical affairs dr olanoff holds a phd degree in biomedical engineering and an md degree from case western reserve university   lawrence olanoff colleagues  name title email kris venkat board dir please login max link chmn please login gregory weaver board dir please login augustine chow board dir please login gary pace board dir please login             home    about us    product information     subscription    list builder     executive list     email lists     contact us    site map    browse directory      �  walkerss research  a publisher of business information since  all rights reserved ariel pharmaceuticals appoints board chair the colorado bioscience association homenewsinstitutemember logincontact usfacebooktwitterlinkedinyoutube about ussponsorshipmembershipprograms  eventsjobs  resumesadvocacyresources news ariel pharmaceuticals appoints board chair ariel pharmaceuticals inc appoints forest laboratories inc veteran as chairman of the companys board of directors lawrence s olanoff md phd to serve as chairman and to advise ariel on the development of its lead compounds broomfield co may    ariel pharmaceuticals a private developmentstage specialty pharmaceutical company focused on the development and commercialization of products for major unmet medical needs announced today it has appointed lawrence s olanoff md phd as chairman of the companys board of directors bod with more than  years in healthcare dr olanoff is a seasoned industry veteran and were eager to benefit from his insights and experience as we advance ariels lead programs through the clinic said steve orndorff president and ceo of ariel pharmaceuticals  we believe we have a welldevised strategy for moving the company forward and im confident the addition of dr olanoff will add to our success as we aim to achieve several milestones in the near future including phase ii results of our lead compound ap a bestinclass ep receptor antagonist dr olanoff was most recently president and chief operating officer for forest laboratories inc from  through  and continues to serve as a director  from  to  he was responsible for the leadership of research and development activities for the company while serving as forests executive vice president of scientific affairs  dr olanoff was also appointed president and ceo of celsion corporation from  to  adding to his industry experience dr olanoff was previously senior vice president of clinical research and development for sandoz pharmaceutical corporation  for nearly a decade prior to sandoz dr olanoff held multiple positions at the upjohn company where his last position was corporate vice president of clinical development and medical affairs  since  dr olanoff has directed the development of  approved ndas or supplemental ndas including such major products as namenda® lexapro® and neoral® in addition to serving as chairman of ariels bod dr olanoff is currently special advisor to the president for corporate relations at medical university of south carolina musc dr olanoff remarked given the strong scientific background and pedigree of the current members of ariels management team board of directors and scientific advisory board as well as the quality of the developmental pipeline i believe the company is wellpositioned for success moving forward  having been previously involved in the development of antiinflammatory analgesic agents and eicosanoid research i am particularly interested in the ep receptor target selected by ariel and am delighted to have the opportunity to participate as a member of the board as the company advances its lead programs through development dr olanoff earned his md and phd in biomedical engineering from case western reserve university and was a medical resident and clinical pharmacology fellow at musc  he has authored or coauthored numerous scientific publications in clinical pharmacology drug delivery and pharmacokinetics about ariel pharmaceuticals inc ariel pharmaceuticals inc is a private developmentstage specialty pharmaceutical company focused on the development and commercialization of drugs that improve quality of life for patients with major unmet medical needs  the companys business strategy is based on inlicensing of clinicready drugs in acute care clinical indications that have hard welldefined endpoints that make it possible to rapidly build shareholder value  ariels lead product ap is a bestinclass ep receptor antagonist in phase ii clinical development for osteoarthritis and acute migraine  for more information please visit wwwarielpharmacom  download announcement   go back previous next regional news business wire globe newswire rss feed categories cbsa in the news  company news  expansions company  industry news  institute news  media room  policy updates  press releases  publications  video  more colorado bio news recent posts inspiring the next generation through research experience for teachersamgen and array biopharma announce preclinical license and collaboration agreement in inflammationwhy choose coloradoindevr cypher one™ collaborative study with fda publishedantriabio closes m private placement archive july  june  may  april  march  february  january  december  november  october  september  august   sustaining sponsor fitz redev auth fitz redev auth titanium sponsor boettcher foundation fisher platinum sponsor colorado state university cooley cu dorsey ey new phrma gold sponsor astrazeneca dohmenlss hogan lovells sheridan ross snell  wilmer silver sponsor amgen crowe horwath glaxo medtronic somalogic terumobct bronze sponsor allosource cobiz financial eksh genentech johnson  johnson king  spalding merck oedit pfizer tolmar trinet terms of useprivacy policysite mapcopyright   all rights reserved design by hotpress web